Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 8601063, 8 pages
https://doi.org/10.1155/2017/8601063
Research Article

Comparative Assessment of Cytokine Pattern in Early and Late Onset of Neonatal Sepsis

1Kazan State Medical University, Kazan, Russia
2Kazan Federal University, Kazan, Russia
3Nevada Center for Biomedical Research, Reno, NV, USA
4Republic Children’s Clinical Hospital, Kazan, Russia

Correspondence should be addressed to S. V. Boichuk; ur.liam@iegreskuhciob and A. A. Rizvanov; ur.ufpk@vonavzir.trebla

Received 10 October 2016; Accepted 20 February 2017; Published 5 March 2017

Academic Editor: Levon Abrahamyan

Copyright © 2017 Kh. S. Khaertynov et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Camacho-Gonzalez, P. W. Spearman, and B. J. Stoll, “Neonatal infectious diseases: evaluation of neonatal sepsis,” Pediatric Clinics of North America, vol. 60, no. 2, pp. 367–389, 2013. View at Publisher · View at Google Scholar
  2. J. L. Wynn and O. Levy, “Role of innate host defenses in susceptibility to early-onset neonatal sepsis,” Clinics in Perinatology, vol. 37, no. 2, pp. 307–337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Frost, H. Newsham, S. Parmar, and A. Gonzalez-Ruiz, “Impact of delayed antimicrobial therapy in septic ITU patients,” Critical Care, vol. 14, supplement 2, p. P20, 2010. View at Publisher · View at Google Scholar
  4. K. Reinhart, M. Bauer, N. C. Riedemann, and C. S. Hartog, “New approaches to sepsis: molecular diagnostics and biomarkers,” Clinical Microbiology Reviews, vol. 25, no. 4, pp. 609–634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Torres-Martos, M. Pérez-Ruiz, I. Pedrosa-Corral et al., “Evaluation of the LightCycler® SeptiFast test in newborns and infants with clinical suspicion of sepsis,” Enfermedades Infecciosas y Microbiologia Clinica, vol. 31, no. 6, pp. 375–379, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. D. G. Remick, “Pathophysiology of sepsis,” American Journal of Pathology, vol. 170, no. 5, pp. 1435–1444, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. S. Hotchkiss and I. E. Karl, “The pathophysiology and treatment of sepsis,” New England Journal of Medicine, vol. 348, no. 2, pp. 138–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. B. G. Sood, S. Shankaran, R. L. Schelonka et al., “Cytokine profiles of preterm neonates with fungal and bacterial sepsis,” Pediatric Research, vol. 72, no. 2, pp. 212–220, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. A. Polin, L.-A. Papile, J. E. Baley et al., “Management of neonates with suspected or proven early-onset bacterial sepsis,” Pediatrics, vol. 129, no. 5, pp. 1006–1015, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Kocabaş, A. Sarikçioğlu, N. Aksaray, G. Seydaoğlu, Y. Seyhun, and A. Yaman, “Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis,” Turkish Journal of Pediatrics, vol. 49, no. 1, pp. 7–20, 2007. View at Google Scholar · View at Scopus
  11. A. Leviton, T. M. O'Shea, F. J. Bednarek, E. N. Allred, R. N. Fichorova, and O. Dammann, “Systemic responses of preterm newborns with presumed or documented bacteraemia,” Acta Paediatrica, International Journal of Paediatrics, vol. 101, no. 4, pp. 355–359, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Prashant, P. Vishwanath, P. Kulkarni et al., “Comparative assessment of cytokines and other inflammatory markers for the early diagnosis of neonatal sepsis-a case control study,” PLoS ONE, vol. 8, no. 7, Article ID e68426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. European Medicines Agency, Report on the Expert Meeting on Neonatal and Paediatric Sepsis, EMA, London, UK, 2010, http://www.ema.europa.eu/docs/en_GB/document_library/Report/2010/12/WC500100199.pdf.
  14. G. Klinger, I. Levy, L. Sirota, V. Boyko, B. Reichman, and L. Lerner-Geva, “Epidemiology and risk factors for early onset sepsis among very-low-birthweight infants,” American Journal of Obstetrics and Gynecology, vol. 201, no. 1, pp. 38.e1–38.e6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Cohen-Wolkowiez, C. Moran, D. K. Benjamin et al., “Early and late onset sepsis in late preterm infants,” Pediatric Infectious Disease Journal, vol. 28, no. 12, pp. 1052–1056, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Clyne and J. S. Olshaker, “The C-reactive protein,” Journal of Emergency Medicine, vol. 17, no. 6, pp. 1019–1025, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. R. S. Hotchkiss, G. Monneret, and D. Payen, “Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach,” The Lancet Infectious Diseases, vol. 13, no. 3, pp. 260–268, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Reis Machado, D. F. Soave, M. V. Da Silva et al., “Neonatal sepsis and inflammatory mediators,” Mediators of Inflammation, vol. 2014, Article ID 269681, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Bhandari, “Effective biomarkers for diagnosis of neonatal sepsis,” Journal of the Pediatric Infectious Diseases Society, vol. 3, no. 3, pp. 234–245, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Shouman and R. Badr, “Regulated on activation, normal T cell expressed and secreted and tumor necrosis factor-α in septic neonates,” Journal of Perinatology, vol. 30, no. 3, pp. 192–196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Bender, J. Thaarup, K. Varming, H. Krarup, S. Ellermann-Eriksen, and F. Ebbesen, “Early and late markers for the detection of early-onset neonatal sepsis,” Danish Medical Bulletin, vol. 55, no. 4, pp. 219–223, 2008. View at Google Scholar · View at Scopus
  22. S. S. Oguz, E. Sipahi, and U. Dilmen, “C-reactive protein and interleukin-6 responses for differentiating fungal and bacterial aetiology in late-onset neonatal sepsis,” Mycoses, vol. 54, no. 3, pp. 212–216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. Melville and T. J. M. Moss, “The immune consequences of preterm birth,” Frontiers in Neuroscience, vol. 7, article no. 79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Tissières, A. Ochoda, I. Dunn-Siegrist et al., “Innate immune deficiency of extremely premature neonates can be reversed by interferon-γ,” PLoS ONE, vol. 7, no. 3, Article ID e32863, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. A. G. Cuenca, J. L. Wynn, L. L. Moldawer, and O. Levy, “Role of innate immunity in neonatal infection,” American Journal of Perinatology, vol. 30, no. 2, pp. 105–112, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Jabandziev, M. Smerek, J. Michalek Sr. et al., “Multiple gene-to-gene interactions in children with sepsis: a combination of five gene variants predicts outcome of life-threatening sepsis,” Critical Care, vol. 18, no. 1, article no. R1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A.-Q. Zhang, W. Pan, J.-W. Gao et al., “Associations between interleukin-1 gene polymorphisms and sepsis risk: a meta-analysis,” BMC Medical Genetics, vol. 15, no. 1, article 8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. A. A. H. Zeitoun, S. S. Gad, F. M. Attia, A. S. Abu Maziad, and E. F. Bell, “Evaluation of neutrophilic CD64, interleukin 10 and procalcitonin as diagnostic markers of early- and late-onset neonatal sepsis,” Scandinavian Journal of Infectious Diseases, vol. 42, no. 4, pp. 299–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Perlroth, B. Choi, and B. Spellberg, “Nosocomial fungal infections: epidemiology, diagnosis, and treatment,” Medical Mycology, vol. 45, no. 4, pp. 321–346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. Z.-Q. Wang, A. S. Bapat, R. J. Rayanade, A. S. Dagtas, and M. K. Hoffmann, “Interleukin-10 induces macrophage apoptosis and expression of CD16 (FcγRIII) whose engagement blocks the cell death programme and facilitates differentiation,” Immunology, vol. 102, no. 3, pp. 331–337, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. L. A. Bouton, C. D. Ramirez, D. P. Bailey et al., “Costimulation with interleukin-4 and interleukin-10 induces mast cell apoptosis and cell-cycle arrest: the role of p53 and the mitochondrion,” Experimental Hematology, vol. 32, no. 12, pp. 1137–1145, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. D. C. Angus and T. van der Poll, “Severe sepsis and septic shock,” The New England Journal of Medicine, vol. 369, no. 21, pp. 840–851, 2013. View at Google Scholar · View at Scopus